You’re invited to ACT1ON: A twiist premiere.
Don't miss the exclusive reveal of first experiences and data with twiist!
JUNE 20-23, 2025
American Diabetes Association 2025 Scientific Sessions
Chicago, Illinois
Chicago, Illinois
Get Your Simplified Access Pass
Become a twiist A-Lister
Upon arrival to the twiist booth, you’ll receive your Simplified Access Pass—granting you an all-access experience to be among the first to get the scoop on the twiist AID System.
Visit the three screenings and events at ADA 2025 to get an exclusive first look at twiist clinical data.
Visit the three screenings and events at ADA 2025 to get an exclusive first look at twiist clinical data.
SCHEDULE
Simplified Access Pass
Visit our booth
Stop by booth #1329 when you arrive at ADA 2025 to get your Simplified Access Pass for an all-access experience to ACT1ON: a twiist premiere! Get a hands-on demo of the twiist AID System, learn about the integration with the FreeStyle Libre 3 Plus sensor and see brand-new evidence supporting how twiist can help people with type 1 diabetes with adaptive and proactive diabetes management.
GRAND PREMIERE
Attend the Product Theater
Theater 3
June 21st
10:15am-11:00am
This is the premiere you’ve been waiting for. Join us for the exclusive Grand Premiere of the twiist AID System, featuring one of the first glimpses into brand-new clinical data and the real-world use of twiist. Showtime is at 10:15am. Be early, you don’t want to miss the trailers!
June 21st
10:15am-11:00am
This is the premiere you’ve been waiting for. Join us for the exclusive Grand Premiere of the twiist AID System, featuring one of the first glimpses into brand-new clinical data and the real-world use of twiist. Showtime is at 10:15am. Be early, you don’t want to miss the trailers!
Speakers
Dr. Anders Carlson, MD
International Diabetes Center
Dr. Joanna Mitri, MD, MS
Chief Medical Officer, Sequel
Dr. Rosemarie Lajara, MD, FACE
Southern Endocrinology & Diabetes Associates
Dr. Bruce Bode, MD, FACE
Atlanta Diabetes Associates
Adriana Ruiz
PA-C
PA-C
Atlanta Diabetes Associates
Maureen Gamble
twiist User
BEHIND THE SCENES
Visit the Abbott booth
Abbott booth #1611
June 21st
12:30pm-12:50pm
Every great premiere has an afterparty, right? Following the Grand Premiere of twiist at the product theater, head over to the Abbott booth (#1611) on Saturday afternoon for a presentation on early clinical and PWD experiences with the twiist AID System and FreeStyle Libre 3 Plus sensor.
June 21st
12:30pm-12:50pm
Every great premiere has an afterparty, right? Following the Grand Premiere of twiist at the product theater, head over to the Abbott booth (#1611) on Saturday afternoon for a presentation on early clinical and PWD experiences with the twiist AID System and FreeStyle Libre 3 Plus sensor.
CONVERSATION WITH INDUSTRY INSIDERS
Attend Musings at ADA
Venue SIX10 610 S Michigan Ave, Chicago
June 19th
6:00pm (Registration opens at 5:30pm)
Want to hear directly from industry insiders about how innovations in therapy and technology are helping to empower people with diabetes? Attend the Musings at ADA Scientific Sessions at Venue SIX10 to hear from panelists across the industry.
June 19th
6:00pm (Registration opens at 5:30pm)
Want to hear directly from industry insiders about how innovations in therapy and technology are helping to empower people with diabetes? Attend the Musings at ADA Scientific Sessions at Venue SIX10 to hear from panelists across the industry.
COMING ATTRACTIONS
Visit the Eversense booth
Eversense booth #2215
The twiist AID System will be the first AID system compatible with Eversense 365, the world's first and only one-year CGM system, offering people with type 1 diabetes a new level of flexibility and personalization in how they manage their diabetes. Visit booth #2215 to learn more about this exciting partnership.
The twiist AID System will be the first AID system compatible with Eversense 365, the world's first and only one-year CGM system, offering people with type 1 diabetes a new level of flexibility and personalization in how they manage their diabetes. Visit booth #2215 to learn more about this exciting partnership.
TALK TO THE CAST AND CREW AHEAD OF THE PREMIERE
Ready for the cinematic event of the Summer?
Lights. Camera. ACT1ON! If you’re attending ADA 2025, our cast and crew are available for meet and greets. Do you have questions about the twiist AID System, want to partner with us, or want to explore new ways to collaborate? Let’s talk shop!
Indications for Use
twiist AID System Indications for Use
The twiist System is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, ages six and above. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The twiist system is intended for single patient, home use and requires a prescription.
Simple Bolus Calculator Indications for Use
The twiist Automated Insulin Delivery System includes a simple bolus calculator available when Loop is off. It is indicated for use for aiding the user in determining the bolus insulin dosage for management of diabetes mellitus based on consumed carbohydrates, operator entered blood glucose, insulin sensitivity, insulin to carbohydrate ratio, target glucose values, and current insulin on board.
twiist Loop Algorithm Indications for Use
The twiist Loop algorithm is intended for use with compatible integrated continuous glucose monitors (iCGMs) and the twiist alternate controller enabled (ACE) insulin infusion pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also recommend, and with the user's confirmation, control the delivery of correction boluses when glucose values are predicted to exceed user configurable thresholds.
The twiist Loop algorithm is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. The twiist Loop is intended for single patient use and requires a prescription.
twiist AID System Indications for Use
The twiist System is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin, ages six and above. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The twiist system is intended for single patient, home use and requires a prescription.
Simple Bolus Calculator Indications for Use
The twiist Automated Insulin Delivery System includes a simple bolus calculator available when Loop is off. It is indicated for use for aiding the user in determining the bolus insulin dosage for management of diabetes mellitus based on consumed carbohydrates, operator entered blood glucose, insulin sensitivity, insulin to carbohydrate ratio, target glucose values, and current insulin on board.
twiist Loop Algorithm Indications for Use
The twiist Loop algorithm is intended for use with compatible integrated continuous glucose monitors (iCGMs) and the twiist alternate controller enabled (ACE) insulin infusion pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also recommend, and with the user's confirmation, control the delivery of correction boluses when glucose values are predicted to exceed user configurable thresholds.
The twiist Loop algorithm is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. The twiist Loop is intended for single patient use and requires a prescription.
Contraindications
The twiist automated insulin delivery system is not intended for anyone unable or unwilling to:
The twiist automated insulin delivery system is not intended for anyone unable or unwilling to:
- Test blood glucose (BG) levels as recommended by their healthcare provider
- Maintain sufficient diabetes selfcare skills.
- See their healthcare provider regularly
- Demonstrate adequate carbohydrate-counting skills (preferred, not required).
The user must not:
- Have difficulty seeing
- Have difficulty hearing
- Have deficient cognitive capabilities
- Have physical impairments that would make operating the pump or iPhone difficult
Please visit twiist.com/safety for important safety information.
Product only available in the U.S.
“twiist,” “iiSure,” and the twiist logo are trademarks of Sequel Med Tech, LLC. “Tidepool” and the Tidepool logo are registered trademarks of Tidepool Project, a fully-qualified 501(c)(3) nonprofit organization. All other registered trademarks are the property of their respective owners. ©2025 Sequel Med Tech, LLC. All rights reserved. MAT-0174 V 1.0 05/25
For full FreeStyle Libre 3 Plus sensor safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.
Product only available in the U.S.
“twiist,” “iiSure,” and the twiist logo are trademarks of Sequel Med Tech, LLC. “Tidepool” and the Tidepool logo are registered trademarks of Tidepool Project, a fully-qualified 501(c)(3) nonprofit organization. All other registered trademarks are the property of their respective owners. ©2025 Sequel Med Tech, LLC. All rights reserved. MAT-0174 V 1.0 05/25
For full FreeStyle Libre 3 Plus sensor safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.